+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Opioid Use Disorder Market, by Drug Type, by Route of Administration, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • PDF Icon

    Report

  • 198 Pages
  • August 2021
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5417306
Opioids, used medically for pain relief, have analgesic and central nervous system depressant effects as well as the potential to cause euphoria. Opioid use disorder (OUD) can involve misuse of prescribed opioid medications, use of diverted opioid medications, or use of illicitly obtained heroin. OUD is typically a chronic, relapsing illness, associated with significantly increased rates of morbidity and mortality. In patients with OUD who have achieved abstinence through medically supervised withdrawal or by other means, maintenance treatment aims to prevent relapse. Options for long-term maintenance treatment include an opioid agonist (i.e., methadone or buprenorphine), an opioid antagonist (naltrexone), or non-medication, abstinence-based treatment.



Market Dynamics


Increasing incidences of pain associated with chronic diseases such as cancer, rising cases of opioid addiction, and increasing adoption of inorganic growth strategies by key players in order to expand their product portfolio in the global opioid use disorder market. The general population nowadays suffers from a wide range of chronic and severe health conditions, such as pain arising from injuries or cancer. They often result in chronic pain and in such cases, patients are given painkillers, especially opioids. While they help in lowering pain, they can cause addiction among patients. The abrupt discontinuation or higher dependency on these drugs leads to withdrawal symptoms. This further increases the chances of fatal consequences, such as deaths.

For instance, The American Psychiatric Association (APA), stated that approximately 72,000 Americans died due to opioid overdose in 2017. These factors are likely to drive the opioid use disorder market growth in the near future.

Key features of the study:

  • This report provides in-depth analysis of the global opioid use disorder market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global opioid use disorder market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Indivior PLC, Alkermes, Orexo AB, Titan Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, BioDelivery Sciences International Inc., Viatris Inc., Pfizer, Inc., Hikma Pharmaceuticals PLC, and Camurus
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global opioid use disorder market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global opioid use disorder market

Detailed Segmentation:


Global Opioid Use Disorder Market, By Drug Type:

  • Buprenorphine
  • Methadone
  • Naltrexone
  • Others

Global Opioid Use Disorder Market, By Route of Administration:

  • Oral
  • Parenteral

Global Opioid Use Disorder Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Opioid Use Disorder Market, By Region:

  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country
  • South Africa
  • Central Africa
  • North Africa

Company Profiles

  • Indivior PLC *
  • Company Overview
  • Material Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • Alkermes
  • Orexo AB
  • Titan Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mallinckrodt Pharmaceuticals
  • BioDelivery Sciences International Inc.
  • Viatris Inc.
  • Pfizer, Inc.
  • Hikma Pharmaceuticals PLC
  • Camurus
“*” marked represents similar segmentation in other categories in the respective section.
Frequently Asked Questions about the Opioid Use Disorder Market

What is the estimated value of the Opioid Use Disorder Market?

The Opioid Use Disorder Market was estimated to be valued at $2739.2 Million in 2021.

What is the growth rate of the Opioid Use Disorder Market?

The growth rate of the Opioid Use Disorder Market is 8.7%, with an estimated value of $4911.8 Million by 2028.

What is the forecasted size of the Opioid Use Disorder Market?

The Opioid Use Disorder Market is estimated to be worth $4911.8 Million by 2028.

Who are the key companies in the Opioid Use Disorder Market?

Key companies in the Opioid Use Disorder Market include Indivior PLC, Alkermes, Orexo AB, Titan Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, BioDelivery Sciences International Inc., Viatris Inc. and Hikma Pharmaceuticals PLC.

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Route of Administration
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Pipeline Analysis
  • PEST Analysis
  • Epidemiology
  • Regulatory Scenario
  • Reimbursement Scenario
  • Acquisitions and Collaboration
  • Brand Analysis

4. Global Opioid Use Disorder Market - Impact of Coronavirus (COVID-19) Pandemic
  • Economic Impact
  • Impact on Opioid Use Disorder Market
  • Impact on Drug Development

5. Global Opioid Use Disorder Market, By Drug Type, 2017 - 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Buprenorphine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Methadone
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Naltrexone
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Opioid Use Disorder Market, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Opioid Use Disorder Market, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

8. Global Opioid Use Disorder Market, By Region, 2017 - 2028, (US$ Mn)
  • Introduction
  • Market Share Analysis, By Region, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018-2028
  • North America
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Landscape
  • Heat Map Analysis
  • Market Share Analysis
  • Indivior PLC*
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Alkermes
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Orexo AB
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Titan Pharmaceuticals, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Mallinckrodt Pharmaceuticals
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • BioDelivery Sciences International Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Viatris Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Pfizer, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Hikma Pharmaceuticals PLC
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Camurus
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Analyst Views

10. Section
  • References
  • Research Methodology
  • About us and Sales Contact

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Indivior PLC
  • Alkermes
  • Orexo AB
  • Titan Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mallinckrodt Pharmaceuticals
  • BioDelivery Sciences International Inc.
  • Viatris Inc.
  • Pfizer, Inc.
  • Hikma Pharmaceuticals PLC
  • Camurus